EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients

Vivek Subbiah, Martin Dietrich

Targeted Oncology · 2026-05 · 21 (3) · 321-326

DOI: 10.1007/s11523-026-01215-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Targeted Oncology, online erschienen am 13.05.2026. Verfasst von Vivek Subbiah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. viveksubbiah@outlook.com. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Erb-b2 Receptor Tyrosine Kinases, Lung Neoplasms. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungErb-b2 Receptor Tyrosine KinasesLung NeoplasmsHumansMutation

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. viveksubbiah@outlook.com.
  • The US Oncology Network and Cancer Care Centers of Brevard, Orlando, FL, USA.

Förderung

  • Bayer

Zitieren

APA

Subbiah, V., & Dietrich, M. (2026). HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients. Targeted Oncology, 21(3), 321-326. https://doi.org/10.1007/s11523-026-01215-2

Vancouver

Subbiah V, Dietrich M. HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients. Targeted Oncology. 2026;21(3):321-326. doi:10.1007/s11523-026-01215-2

BibTeX
@article{Subbiah2026,
  author = {Subbiah, Vivek and Dietrich, Martin},
  title = {HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients},
  journal = {Targeted Oncology},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {321--326},
  doi = {10.1007/s11523-026-01215-2}
}
Kostenlos starten →